TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS
$2,579,355N01FY2021AINIH
University Of Alabama At Birmingham, Birmingham AL
Investigators
Abstract
To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy.
View original record on NIH RePORTER →